Sundar PichaiSundar Pichai earned $164M in 2023

While at Pacific Biosciences, Michael Hunkapiller saw significant fluctuations in his stock holdings alongside the company’s stock value. Notably, in 2019, his holdings peaked with insider trades valued at $12.22M, showing strong interest in the company’s performance. This trend continued...

Stock Sold

$140.92M

PACB

$140.92M

7,042,889 PACB shares

What if they kept their stock?

If Michael Hunkapiller didn't sell their stock, today they would have:
Extra PACB7,042,889 shares worth $8.52M.
This is -93.95% and $132.39M less than what they got when they sold the stock.

Recent Insider Trades

PACB

$7.51M

PACB at $32.06/share

Feb 26, 2021

Sale

PACB

$11.34M

PACB at $33.42/share

Feb 24, 2021

Sale

PACB

$9.85M

PACB at $36.96/share

Feb 24, 2021

Sale

PACB

$12.68M

PACB at $33.96/share

Feb 22, 2021

Sale

PACB

$8.97M

PACB at $39.15/share

Feb 22, 2021

Sale

PACB

$4.58M

PACB at $36.53/share

Jan 25, 2021

Sale

PACB

$5.55M

PACB at $36.80/share

Jan 20, 2021

Sale

PACB

$9.59M

PACB at $37.08/share

Jan 20, 2021

Sale

PACB

$8.61M

PACB at $40.06/share

Jan 20, 2021

Sale

PACB

$9.39M

PACB at $25.76/share

Dec 21, 2020

Sale

Michael Hunkapiller

Ex-CEO of Pacific Biosciences of California

MH

View Compensation History

2020 Total Compensation

$5.04M

Salary

$582.90K

Bonus

$0.00

Stock

$3.87M

Other

$582.90K